Department of Neurosurgery, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
Neuromodulation. 2021 Dec;24(8):1370-1376. doi: 10.1111/ner.13351. Epub 2021 Feb 9.
In adult scoliosis, dorsal instrumentation and fusion can provide significant improvement of pain and disability scores (Owestry Index); however, complication rates of up to 39% have been reported. As such, recent attempts have been made at expanding the surgical spectrum to include less invasive techniques in patients such as neuromodulation, specifically spinal cord stimulation (SCS). We therefore aimed to evaluate its use in a larger cohort of adult scoliosis patients in the form of a pilot study.
We analyzed prospectively collected data from 18 adult scoliosis patients receiving SCS treatment in our institution between February 2019 and May 2020. Clinical follow-up was performed at 3, 6, and 12 months following implantation of an epidural SCS System. Patients reported numeric rating scale (NRS) values for the categories of lower back pain (LBP) and regional pain (RP) both at rest and in motion. Further, SF-36, ADS-K, PSQI, and ODI forms were completed. The study was approved by the institutional Ethics Committee (EA2/093/13).
Initial preoperative NRS of LBP at rest was significantly reduced following SCS at three (45% reduction, p = 0.005) and six (43% reduction, p = 0.009) months follow-up. LBP in motion was also reduced at three (27% reduction, p = 0.002) and six (33% reduction vs. preoperative, p = 0.005) months. RP at rest was reduced at three (38% reduction, p = 0.003) and six (37% reduction, p = 0.007) and in movement at three (29% reduction, 0.006) and six (32% reduction, p = 0.011). Loss of thoracic kyphosis and increased pelvic incidence were associated with worse NRS response to SCS stimulation at six months follow-up.
In overweight, older adults for whom the risks of corrective surgery must be carefully considered, neuromodulation can significantly reduce LBP as well as regional pain in the first six months following implantation. These findings may provide a reasonable alternative in patients not willing or eligible to undergo extensive corrective surgery.
在成人脊柱侧弯中,后路器械固定融合术可显著改善疼痛和残疾评分(Oswestry 指数);然而,其并发症发生率高达 39%。因此,最近尝试将手术范围扩大到包括神经调节等微创技术,特别是脊髓刺激(SCS)。为此,我们旨在通过一项初步研究,评估 SCS 在更大的成人脊柱侧弯患者队列中的应用。
我们分析了 2019 年 2 月至 2020 年 5 月期间在我院接受 SCS 治疗的 18 例成人脊柱侧弯患者前瞻性收集的数据。在硬膜外 SCS 系统植入后 3、6 和 12 个月进行临床随访。患者报告下腰痛(LBP)和区域疼痛(RP)在休息和运动时的数字评分量表(NRS)值。此外,还完成了 SF-36、ADS-K、PSQI 和 ODI 表格。该研究得到了机构伦理委员会(EA2/093/13)的批准。
SCS 术后 3 个月时,静息时的初始术前 LBP NRS 显著降低(45%的降低,p=0.005),6 个月时进一步降低(43%的降低,p=0.009)。运动时的 LBP 也在 3 个月时(27%的降低,p=0.002)和 6 个月时(与术前相比 33%的降低,p=0.005)降低。静息时的 RP 在 3 个月时(38%的降低,p=0.003)和 6 个月时(37%的降低,p=0.007)以及运动时在 3 个月时(29%的降低,p=0.006)和 6 个月时(32%的降低,p=0.011)降低。胸椎后凸丢失和骨盆入射角增加与 SCS 刺激后 6 个月时的 NRS 反应较差相关。
对于超重和年龄较大的成年人,需要谨慎考虑手术矫正的风险,神经调节可以在植入后最初的 6 个月内显著减轻下腰痛和区域疼痛。对于不愿意或不适合接受广泛矫正手术的患者,这些发现可能提供了一个合理的替代选择。